Skip to content

Molecular Characterization of Spinal Tissue

Molecular Characterization of Spinal Tissue

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03492372
Enrollment
300
Registered
2018-04-10
Start date
2015-03-31
Completion date
2027-07-01
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Diseases

Brief summary

The researchers are trying to identify molecular mechanisms that control spine deformity and degenerative changes that can be used for therapeutic strategies.

Detailed description

Discarded surgical material from spinal procedures is collected. RNA analysis and other tests on the tissue is performed to determine markers of pathologic disease and to develop pharmacologic treatment strategies for pediatric spinal disorders.

Interventions

OTHERWaste tissues are collected at the time of spinal surgery.

This is a single visit study. Waste tissues are collected at the time of spinal surgery.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Children and adults undergoing surgical procedures where spinal tissues are removed as a normal part of their procedure. Material from adults may be collected as a control group.

Exclusion criteria

* Surgeries where spinal tissues are not being removed.

Design outcomes

Primary

MeasureTime frameDescription
RNA expressionBaselineMeasure RNA levels in spinal tissues samples (ng/mL)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORA.Noelle Larson, MD

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026